Currently out of the existing stock ratings of Eric Joseph, 138 are a BUY (57.98%), 82 are a HOLD (34.45%), 18 are a SELL (7.56%).

Eric Joseph

Work Performance Price Targets & Ratings Chart

Analyst Eric Joseph, currently employed at JPMORGAN, carries an average stock price target met ratio of 61.3% that have a potential upside of 50.56% achieved within 192 days.

Eric Joseph’s has documented 440 price targets and ratings displayed on 48 stocks. The coverage is on Healthcare, Basic Materials, Technology sectors.

Most recent stock forecast was given on CAMP, CalAmp Corp at 16-Jun-2026.

Wall Street Analyst Eric Joseph

Analyst best performing recommendations are on DTIL (PRECISION BIOSCIENCES).
The best stock recommendation documented was for VERV (VERVE THERAPEUTICS) at 7/12/2021. The price target of $50 was fulfilled within 1 day with a profit of $1.8 (3.73%) receiving and performance score of 37.34.

Average potential price target upside

AKBA Akebia Ther ALGS Aligos Therapeutics  AUTL Autolus Therapeutics Ltd AVIR Atea Pharmaceuticals  BDTX Black Diamond Therapeutics BEAM Beam Therapeutics  ENTA Enanta Pharmaceuticals FPRX Five Prime Therapeutics KPTI Karyopharm Therapeutics MNTA Momenta Pharmaceuticals MYOV Myovant Sciences Ltd NRIX Nurix Therapeutics  NVAX Novavax OBSV ObsEva SA OMER Omeros PTCT PTC Therapeutics RLAY Relay Therapeutics  RCKT Rocket Pharmaceuticals HGEN Humanigen IRWD Ironwood Pharmaceuticals TERN Terns Pharmaceuticals XLRN Acceleron Pharma CCCC C4 Therapeutics  SRZN Surrozen DTIL Precision BioSciences FRLN Freeline Therapeutics Holdings Plc IGMS IGM Biosciences OPK Opko Health PLRX Pliant Therapeutics  RVMD Revolution Medicines BMEA Biomea Fusion KYMR Kymera Therapeutics MRTX Mirati Ther GLUE Monte Rosa Therapeutics TGTX TG Therapeutics VIR Vir Biotechnology AKRO Akero Therapeutics IPSC Century Therapeutics LTHM Livent Corp RXRX Recursion Pharmaceuticals BLUE Bluebird bio VERV Verve Therapeutics WVE Wave Life Sciences Ltd HLVX Hillevax PRME Prime Medicine, Common Stock CAMP CalAmp Corp URGN UroGen Pharma Ltd FR First Industrial Realty Trust

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 04-Jun-2025

$6

$4.76 (383.87%)

$6

8 days ago
(01-Jul-2026)

0/5 (0%)

$4.79 (395.87%)

Buy Since 29-Nov-2023

$4

$2.86 (250.88%)

$4

3 months 2 days ago
(07-Apr-2026)

3/7 (42.86%)

$2.62 (189.86%)

578

Buy Since 30-Mar-2022

$4

$2.86 (250.88%)

$2

5 months 3 days ago
(06-Feb-2026)

1/2 (50%)

$2.61 (187.77%)

722

Buy Since 27-Sep-2023

$7.5

$6.36 (557.89%)

$7.5

1 years 3 months 5 days ago
(04-Apr-2025)

15/35 (42.86%)

$5.73 (323.73%)

342

Buy Since 01-Apr-2025

$6

$4.86 (426.32%)

1 years 3 months 8 days ago
(01-Apr-2025)

0/1 (0%)

$4.09 (214.14%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Eric Joseph is most bullish on?

Potential upside of $4.57 has been obtained for CAMP (CALAMP CORP)

What Year was the first public recommendation made by Eric Joseph?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?